{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:58:02Z","timestamp":1792900682472,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Innovation Joint Fund project of Fujian province","award":["2023Y9060"],"award-info":[{"award-number":["2023Y9060"]}]},{"name":"Young and Middle-aged Talents Training Project of Fujian Provincial Health Commission","award":["2024GGA033"],"award-info":[{"award-number":["2024GGA033"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32201153"],"award-info":[{"award-number":["32201153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62275048"],"award-info":[{"award-number":["62275048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Planning Project of Fujian Province","award":["2023J01292"],"award-info":[{"award-number":["2023J01292"]}]},{"name":"Science and Technology Planning Project of Fujian Province","award":["2021J05031"],"award-info":[{"award-number":["2021J05031"]}]},{"name":"Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China","award":["2022ZQNZD006"],"award-info":[{"award-number":["2022ZQNZD006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03609-2","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T05:17:15Z","timestamp":1753161435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["CuOTeDsP nanotherapeutics enhance cuproptosis-mediated immunotherapy by modulating cholesterol metabolism in bladder cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Hai","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangqian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"3609_CR1","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.3390\/ijms25179696","volume":"25","author":"E Tonni","year":"2024","unstructured":"Tonni E, Oltrecolli M, Pirola M, Tchawa C, Roccabruna S, D\u2019Agostino E, Matranga R, Piombino C, Pipitone S, Baldessari C. New advances in metastatic urothelial cancer: a narrative review on recent developments and future perspectives. Int J Mol Sci. 2024;25:9696.","journal-title":"Int J Mol Sci"},{"key":"3609_CR2","unstructured":"U. GLOBOCAN New global cancer data. UICC. 2020, 27, 2022."},{"key":"3609_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74:229\u201363.","journal-title":"Cancer J Clin"},{"key":"3609_CR4","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W. He. Cancer incidence and mortality in china, 2022. J Natl Cancer Cent. 2024;4:47\u201353.","journal-title":"J Natl Cancer Cent"},{"key":"3609_CR5","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K. Mshs. Bladder cancer: a review. JAMA. 2020;324:1980\u201391.","journal-title":"JAMA"},{"key":"3609_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/bmb\/ldy034","volume":"128","author":"SJ Crabb","year":"2018","unstructured":"Crabb SJ, Douglas J. The latest treatment options for bladder cancer. Br Med Bull. 2018;128:85\u201395.","journal-title":"Br Med Bull"},{"key":"3609_CR7","first-page":"1","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y. Bladder cancer. Nat Reviews Disease Primers. 2017;3:1\u201319.","journal-title":"Nat Reviews Disease Primers"},{"key":"3609_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11864-013-0271-3","volume":"15","author":"R Nadal","year":"2014","unstructured":"Nadal R, Bellmunt J. New treatments for bladder cancer: when will we make progress? Curr Treat Options Oncol. 2014;15:99\u2013114.","journal-title":"Curr Treat Options Oncol"},{"key":"3609_CR9","doi-asserted-by":"publisher","first-page":"2212267","DOI":"10.1002\/adma.202212267","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo B, Yang F, Zhang L, Zhao Q, Wang W, Yin L, Chen D, Wang M, Han S. Xiao. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy. Adv Mater. 2023;35:2212267.","journal-title":"Adv Mater"},{"key":"3609_CR10","first-page":"65","volume":"7","author":"O Fuge","year":"2015","unstructured":"Fuge O, Vasdev N, Allchorne P, Green JS. Immunotherapy for bladder cancer. Res Rep Urol. 2015;7:65\u201379.","journal-title":"Res Rep Urol"},{"key":"3609_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/cancers12051181","volume":"12","author":"M Wo\u0142\u0105cewicz","year":"2020","unstructured":"Wo\u0142\u0105cewicz M, Hrynkiewicz R, Grywalska E, Suchojad T, Leksowski T, Roli\u0144ski J. Nied\u017awiedzka-Rystwej. Immunotherapy in bladder cancer: current methods and future perspectives. Cancers. 2020;12:1181.","journal-title":"Cancers"},{"key":"3609_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer. 2023;22:46.","journal-title":"Mol Cancer"},{"key":"3609_CR13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"3609_CR14","doi-asserted-by":"crossref","unstructured":"Liao Y, Wang D, Gu C, Wang X, Zhu S, Zheng Z, Zhang F, Yan J. Z. Gu. A Cuproptosis nanocapsule for cancer radiotherapy. Nat Nanotechnol. 2024, 1\u201311.","DOI":"10.1038\/s41565-024-01784-1"},{"key":"3609_CR15","doi-asserted-by":"publisher","first-page":"101911","DOI":"10.1016\/j.nantod.2023.101911","volume":"51","author":"Q-X Huang","year":"2023","unstructured":"Huang Q-X, Liang J-L, Chen Q-W, Jin X-K, Niu M-T, Dong C-Y. Zhang. Metal-organic framework nanoagent induces Cuproptosis for effective immunotherapy of malignant glioblastoma. Nano Today. 2023;51:101911.","journal-title":"Nano Today"},{"key":"3609_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R. Targeting Cuproplasia and Cuproptosis in cancer. Nat Reviews Clin Oncol. 2024;21:370\u201388.","journal-title":"Nat Reviews Clin Oncol"},{"key":"3609_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/imr.13276","volume":"321","author":"WQ Liu","year":"2024","unstructured":"Liu WQ, Lin WR, Yan L, Xu WH. Yang. Copper homeostasis and Cuproptosis in cancer immunity and therapy. Immunol Rev. 2024;321:211\u201327.","journal-title":"Immunol Rev"},{"key":"3609_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and Cuproptosis in health and disease. Signal Transduct Target Therapy. 2022;7:378.","journal-title":"Signal Transduct Target Therapy"},{"key":"3609_CR19","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint Blockade. Science. 2018;359:1350\u20135.","journal-title":"Science"},{"key":"3609_CR20","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3390\/biomedicines12081832","volume":"12","author":"S Yang","year":"2024","unstructured":"Yang S, Ye Z, Ning J, Wang P, Zhou X, Li W, Cheng F. Cholesterol metabolism and urinary system tumors. Biomedicines. 2024;12:1832.","journal-title":"Biomedicines"},{"key":"3609_CR21","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1021\/jacs.3c08622","volume":"146","author":"Y Liu","year":"2024","unstructured":"Liu Y, Niu R, Zhao H, Wang Y, Song S, Zhang H, Zhao Y. Single-site nanozymes with a highly conjugated coordination structure for antitumor immunotherapy via Cuproptosis and cascade-enhanced T lymphocyte activity. J Am Chem Soc. 2024;146:3675\u201388.","journal-title":"J Am Chem Soc"},{"key":"3609_CR22","doi-asserted-by":"publisher","first-page":"2307752","DOI":"10.1002\/adma.202307752","volume":"36","author":"Y Liu","year":"2024","unstructured":"Liu Y, Niu R, Deng R, Wang Y, Song S, Zhang H. Multi-enzyme co-expressed nanomedicine for anti-metastasis tumor therapy by up-regulating cellular oxidative stress and depleting cholesterol. Adv Mater. 2024;36:2307752.","journal-title":"Adv Mater"},{"key":"3609_CR23","unstructured":"Huang B, Song B-l, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metabolism. 2020, 1\u201310."},{"key":"3609_CR24","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.7150\/jca.38598","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Wang L, Jia R. Role of de Novo cholesterol synthesis enzymes in cancer. J Cancer. 2020;11:1761.","journal-title":"J Cancer"},{"key":"3609_CR25","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.3390\/ijms25073874","volume":"25","author":"L Zhang","year":"2024","unstructured":"Zhang L, Cao Z, Hong Y, He H, Chen L, Yu Z. Gao. Squalene epoxidase: its regulations and links with cancers. Int J Mol Sci. 2024;25:3874.","journal-title":"Int J Mol Sci"},{"key":"3609_CR26","doi-asserted-by":"publisher","first-page":"e1586","DOI":"10.1002\/ctm2.1586","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ma X, Xu E, Huang Z, Yang C, Zhu K, Dong Y. Zhang. Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence\u2010derived prognostic index. Clin Translational Med. 2024;14:e1586.","journal-title":"Clin Translational Med"},{"key":"3609_CR27","doi-asserted-by":"publisher","first-page":"622908","DOI":"10.3389\/fcell.2021.622908","volume":"9","author":"R Vona","year":"2021","unstructured":"Vona R, Iessi E, Matarrese P. Role of cholesterol and lipid rafts in cancer signaling: a promising therapeutic opportunity? Front Cell Dev Biology. 2021;9:622908.","journal-title":"Front Cell Dev Biology"},{"key":"3609_CR28","doi-asserted-by":"crossref","unstructured":"Wu H, Wu X, Zhao M, Yan J, Li C, Zhang Z, Tang S, Wang R. W. Fei. Regulating cholesterol in tumorigenesis: a novel paradigm for tumor nanotherapeutics. Int J Nanomed. 2024;1055\u201376.","DOI":"10.2147\/IJN.S439828"},{"key":"3609_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-019-0945-5","volume":"567","author":"J Garcia-Bermudez","year":"2019","unstructured":"Garcia-Bermudez J, Baudrier L, Bayraktar EC, Shen Y, La K, Guarecuco R, Yucel B, Fiore D, Tavora B. Freinkman. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature. 2019;567:118\u201322.","journal-title":"Nature"},{"key":"3609_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, Wang Q, Yang M, Kalady MF. Qian. Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment. Cell Metabol. 2019;30:143\u201356. e145.","journal-title":"Cell Metabol"},{"key":"3609_CR31","doi-asserted-by":"publisher","first-page":"eabq4722","DOI":"10.1126\/sciadv.abq4722","volume":"8","author":"Q Wang","year":"2022","unstructured":"Wang Q, Cao Y, Shen L, Xiao T, Cao R, Wei S, Tang M, Du L, Wu H, Wu B, Yu Y. Wang. Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs. Sci Adv. 2022;8:eabq4722.","journal-title":"Sci Adv"},{"key":"3609_CR32","doi-asserted-by":"publisher","first-page":"2303567","DOI":"10.1002\/adma.202303567","volume":"35","author":"N Yin","year":"2023","unstructured":"Yin N, Wang Y, Liu Y, Niu R, Zhang S, Cao Y, Lv Z, Song S, Liu X. Zhang. A cholesterol metabolic regulated hydrogen-bonded organic framework (HOF)\u2010based biotuner for antibody non\u2010dependent immunotherapy tailored for glioblastoma. Adv Mater. 2023;35:2303567.","journal-title":"Adv Mater"},{"key":"3609_CR33","doi-asserted-by":"publisher","first-page":"2409967","DOI":"10.1002\/advs.202409967","volume":"12","author":"S Yan","year":"2025","unstructured":"Yan S, Xue P, Sun Y, Bai T, Shao S, Zeng X. Cupric doping Hollow Prussian blue nanoplatform for enhanced cholesterol depletion: a promising strategy for breast cancer therapy and metastasis Inhibition. Adv Sci. 2025;12:2409967.","journal-title":"Adv Sci"},{"key":"3609_CR34","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1136\/gutjnl-2023-331117","volume":"73","author":"J Wen","year":"2024","unstructured":"Wen J, Zhang X, Wong CC, Zhang Y, Pan Y, Zhou Y, Cheung AH-K, Liu Y, Ji F. Kang. Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma. Gut. 2024;73:2023\u201336.","journal-title":"Gut"},{"key":"3609_CR35","doi-asserted-by":"publisher","first-page":"11531","DOI":"10.1021\/jacs.9b03503","volume":"141","author":"W Wu","year":"2019","unstructured":"Wu W, Yu L, Jiang Q, Huo M, Lin H, Wang L, Chen Y. Shi. Enhanced tumor-specific Disulfiram chemotherapy by in situ Cu2+ chelation-initiated nontoxicity-to-toxicity transition. J Am Chem Soc. 2019;141:11531\u20139.","journal-title":"J Am Chem Soc"},{"key":"3609_CR36","doi-asserted-by":"publisher","first-page":"e202213922","DOI":"10.1002\/anie.202213922","volume":"62","author":"J Zhou","year":"2023","unstructured":"Zhou J, Yu Q, Song J, Li S, Li XL, Kang B, Chen HY, Xu JJ. Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy. Angew Chem Int Ed. 2023;62:e202213922.","journal-title":"Angew Chem Int Ed"},{"key":"3609_CR37","doi-asserted-by":"crossref","unstructured":"Park JC, Song H, Kim J, Kwon H. Gram-scale synthesis of Cu2O nanocubes and subsequent oxidation to CuO Hollow nanostructures for lithium-ion battery anode materials. Adv Mater. 2009;21.","DOI":"10.1002\/adma.200800596"},{"key":"3609_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/catal8040171","volume":"8","author":"J Yuan","year":"2018","unstructured":"Yuan J, Zhang J-J, Yang M-P, Meng W-J, Wang H. Lu. CuO nanoparticles supported on TiO2 with high efficiency for CO2 electrochemical reduction to ethanol. Catalysts. 2018;8:171.","journal-title":"Catalysts"},{"key":"3609_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcat.2020.05.018","volume":"389","author":"H Zhang","year":"2020","unstructured":"Zhang H, Tan H-R, Jaenicke S. Chuah. Highly efficient and robust Cu catalyst for non-oxidative dehydrogenation of ethanol to acetaldehyde and hydrogen. J Catal. 2020;389:19\u201328.","journal-title":"J Catal"},{"key":"3609_CR40","doi-asserted-by":"crossref","unstructured":"Hsiao PF, Peng S, Tang T-C, Lin S-Y. H.-C. Tsai. Enhancing the in vivo transdermal delivery of gold nanoparticles using Poly (ethylene glycol) and its oleylamine conjugate. Int J Nanomed. 2016 1867\u201378.","DOI":"10.2147\/IJN.S102599"},{"key":"3609_CR41","doi-asserted-by":"publisher","first-page":"13999","DOI":"10.3390\/ijms232213999","volume":"23","author":"AF Costa","year":"2022","unstructured":"Costa AF, Lu\u00eds S, Noro J, Silva S, Silva C, Ribeiro A. Therapeutic textiles functionalized with keratin-based particles encapsulating terbinafine for the treatment of onychomycosis. Int J Mol Sci. 2022;23:13999.","journal-title":"Int J Mol Sci"},{"key":"3609_CR42","doi-asserted-by":"publisher","first-page":"2306584","DOI":"10.1002\/adfm.202306584","volume":"33","author":"H Tian","year":"2023","unstructured":"Tian H, Duan J, Li B, Qin S, Nice EC, Zhang W, Lang T, Zhang H, Huang C. Clinical chemotherapeutic agent coordinated copper-based nanoadjuvants for efficiently sensitizing cancer chemo\u2010immunotherapy by cuproptosis\u2010mediated mitochondrial metabolic reprogramming. Adv Funct Mater. 2023;33:2306584.","journal-title":"Adv Funct Mater"},{"key":"3609_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.actbio.2023.12.022","volume":"175","author":"W Liang","year":"2024","unstructured":"Liang W, Han C, Zhang D, Liu C, Zhu M, Xu F, Fang C, Zhang S, Liu C, Li Y. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy. Acta Biomater. 2024;175:341\u201352.","journal-title":"Acta Biomater"},{"key":"3609_CR44","doi-asserted-by":"crossref","unstructured":"Zhang Y, Ya S, Huang J, Ju Y, Fang X, Ouyang X, Zeng Q, Zhou X, Yan X, Nie G, Fan K, Zhang B. Spatial isolation of single copper(I) sites for cascade enzyme-like catalysis and simultaneous ferroptosis\/cuproptosis boosted immunotherapy. Exploration. 2025;5: e20240275.","DOI":"10.1002\/EXP.20240275"},{"key":"3609_CR45","doi-asserted-by":"publisher","first-page":"20230134","DOI":"10.1002\/EXP.20230134","volume":"4","author":"Y Luo","year":"2024","unstructured":"Luo Y, He X, Du Q, Xu L, Xu J, Wang J, Zhang W, Zhong Y, Guo D, Liu Y, Chen X. Metal-based smart nanosystems in cancer immunotherapy. Exploration. 2024;4:20230134.","journal-title":"Exploration"},{"key":"3609_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","volume":"229","author":"JL Riley","year":"2009","unstructured":"Riley JL. PD-1 signaling in primary T cells. Immunol Rev. 2009;229:114\u201325.","journal-title":"Immunol Rev"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03609-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03609-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03609-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:18:45Z","timestamp":1757265525000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03609-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3609"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03609-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with protocols approved by the Animal Experimental Ethics Committee of Fujian Normal University (Approval No. IACUC-20250003). Bladder carcinoma and adjacent tissue samples were obtained from patients at the First Affiliated Hospital of Fujian Medical University, with approval from the Ethics Committee (Approval No. MRCTA, ECFAH of FMU [2025]012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"534"}}